Oncopeptides Strengthens its Organization by Appointing Karolina Vilval as General Counsel
“Oncopeptides AB (Nasdaq Stockholm: ONCO) announced … that Karolina Vilval has been appointed as General Counsel of Oncopeptides. Karolina has 15 years of experience from different positions at Swedish Orphan Biovitrum. Prior to joining Oncopeptides, she served as Associate Legal Director at Gilead Sciences Sweden AB for business area Oncology, HIV and Inflammation. She will be a member Oncopeptides’ Management Team,” reports Jakob Lindberg and Rein Piir in Cision PR Newswire’s News.
